Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2016-06-06 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a 'stock buyback program' and provides a table summarizing the number of shares purchased, average price, and transaction value over several days (May 30 to June 3, 2016). This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document length is relatively short (3046 chars) and is a direct report of the transactions, not an announcement of a report.
2016-06-06 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document is a company announcement detailing specific transactions related to Novozymes' share buyback program ('aktietilbagekøbsprogram'). It provides a table of daily share repurchases, total transaction values, and the impact on the company's total treasury shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2016-06-06 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 90% confidence The document is a brief notice stating that Novozymes purchased 2,763,646 shares under its share buyback program. It reports the company’s own share repurchase activity, matching the “Transaction in Own Shares” category.
2016-06-06 Danish
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 100% confidence The document text is very short (254 characters) and written in Danish. It explicitly states that Novozymes bought back a specific number of shares under a previously announced share repurchase program ('aktietilbagekøbsprogram'). This action directly corresponds to the definition of a company buying back its own shares. The final line, 'Læs hele meddelelsen i PDF' (Read the full announcement in PDF), suggests this is a brief notification, but the core content is about share repurchase transactions, which maps directly to the 'Transaction in Own Shares' category (POS). Although it is a short announcement, the specific nature of the transaction (share repurchase) overrides the general 'RPA' fallback.
2016-05-30 Danish
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 99% confidence The document text is titled "Transaktioner i forbindelse med Novozymes' aktietilbagekøbsprogram" (Transactions related to Novozymes' share buyback program). It details the number of shares bought back, the transaction value, and references a specific regulatory framework ("Safe Harbour Regulation"). This content directly relates to the company repurchasing or dealing in its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). The document is a specific report detailing these transactions, not just an announcement of a report's publication.
2016-05-30 English
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document details specific transactions made by Novozymes under its stock buyback program, including a table of daily share purchases, average prices, and transaction values. It also mentions the total number of treasury shares held following these transactions. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers company share buybacks.
2016-05-30 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.